Status:
COMPLETED
Associating Renal Transplantation With the ITN Signature of Tolerance
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Immune Tolerance Network (ITN)
Clinical Trials in Organ Transplantation
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-65 years
Brief Summary
This is an observational study for people who have received a kidney transplant within the past 1 to 5 years. Researchers in this study are looking for a certain pattern of genes and cells in the bloo...
Detailed Description
Following surgery, kidney transplant patients must take medications in order to prevent rejection of their transplanted organ. These medications can be very effective. Called immunosuppressive drugs, ...
Eligibility Criteria
Inclusion
- Received first kidney transplant from a living or deceased donor.
- Kidney transplanted between 1 and 5 years ago.
- Calculated GFR of greater than or equal to 45 mL/min/1.73 m2 within last 6 months
- Ability to understand and provide informed consent.
Exclusion
- History of steroid-resistant acute rejection
- History of two or more episodes of acute rejection
- Any acute rejection in the past year
- Current malignancy
- Transplant of another organ
- AIDS according to the CDC definition of AIDS.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01516177
Start Date
September 1 2010
End Date
April 1 2014
Last Update
December 20 2016
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama Birmingham
Birmingham, Alabama, United States, 35294
2
University of California San Francisco
San Francisco, California, United States, 94143
3
Emory University
Atlanta, Georgia, United States, 30322
4
Northwestern University
Chicago, Illinois, United States, 60611